Search results
Secondary Mitral Regurgitation: Diagnosis and Management
Author(s):
Nehal Dhaduk
,
Adib Chaus
,
David Williams
,
et al
Added:
2 years ago
Review Article
Author(s):
Mark Ricciardi
Added:
1 year ago
HFSA Congress 2024 - Dr Mark Ricciardi (NorthShore Cardiovascular Institute, US) joins us to discuss the findings from the EXPANDed real-world clinical trial on mitral transcatheter edge-to-edge repair with the MitraClip System.The study is designed to confirm the safety and performance of the MitraClip NTR and XTR Systems in mTEER procedures. 1000 patients across 60 sites in Europe and the US…
View more
Author(s):
Ankeet Bhatt
Added:
10 months ago
ESC HF 25 - Secondary analysis of the FINEARTS-HF study shows finerenone treatment favourably influenced the risk of early heart failure readmission.Dr Ankeet Bhatt (Kaiser Permanante San Francisco Medical Center, San Francisco, US) discusses findings from the prespecified secondary analysis of the FINEARTS-HF trial (NCT04435626; Bayer). The placebo-controlled primary analysis investigated the…
View more
Author(s):
Madelyn Hurwitz
,
Olayinka J Agboola
,
Abhishek Gami
,
et al
Added:
11 months ago
Author(s):
Wayne Batchelor
,
Harriette Van Spall
Added:
2 weeks ago
ACC.26 – Late-breaker host Dr Harriette Van Spall (McMaster University, CA) is joined onsite by principal investigator Dr Wayne Batchelor (Inova Schar Heart and Vascular, US) to discuss the ALERT trial. ALERT is a pragmatic, multicentre, cluster-randomised study evaluating the Tempus Next platform, which continuously scans echocardiography reports to identify patients with severe aortic stenosis…
View more
Author(s):
P Kasi Ramanathan
Added:
5 months ago
TCT 2025 - Sub-anlysis findings showed positive safety and efficacy outcomes of the PASCAL Precision system in degenerative mitral regurgitation (DMR) patients.Dr P Kasi Ramanathan (Promedica Toledo Hospital, OH, US) joins us on-site at TCT 2025 to share the findings from a sub-analysis looking at the affect of implant location and leaflet lesion location on the safety and effectiveness of the…
View more
DELINEATE-Regurgitation: AI Accurately Classifies Valvular Regurgitation and Predicts MR Progression
Added:
8 months ago
Source:
Radcliffe Cardiology
News
Author(s):
Stephan Baldus
Added:
1 year ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,…
View more
Author(s):
Firas Zahr
Added:
1 year ago
TCT Conference 24 - Two-year outcomes of CLASP IID shows that the Edwards PASCAL system was noninferior to the Abbott Mitraclip system in transcatheter mitral valve repair for mitral regurgitation.Dr Firas Zahr (Oregon Health and Science University, US) joins us onsite at TCT Conference to discuss the outcomes from the CLASP IID 2 Year RCT and Registry (NCT02371512; Edwards Lifesciences).CLASP…
View more
Author(s):
Claudiu Mihai Ciuciureanu
,
Kristopher Aten
,
Corina Iorgoveanu
Added:
5 months ago